Jonathan B. Mitchem
0000-0002-5385-7038
Publication & Citation Trends
Publications
0 total
Differences in Tumor-Associated T cell receptor repertoires between Early-Onset and Average-Onset colorectal cancer.
Cited by 10
Semantic Scholar
Identification of Genomic Signatures for Colorectal Cancer Survival Using Exploratory Data Mining OA
Cited by 3
Semantic Scholar
Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids OA
Cited by 16
Semantic Scholar
Identifying gene expression programs in single-cell RNA-seq data using linear correlation explanation
Cited by 1
Semantic Scholar
Abstract 4116: Modulating gut microbiota to improve intrahepatic immunity against hepatocellular cancer
Cited by 0
Semantic Scholar
Understanding common key indicators of successful and unsuccessful cancer drug trials using a contrast mining framework on ClinicalTrials.gov OA
Cited by 7
Semantic Scholar
CREATEing Community for Colorectal Surgeon-Scientists.
Cited by 2
Semantic Scholar
Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugs OA
Cited by 0
Semantic Scholar
Research Topics
Epigenetics and DNA Methylation
(60)
Histone Deacetylase Inhibitors Research
(51)
Cancer, Hypoxia, and Metabolism
(45)
Immune cells in cancer
(45)
Cancer Immunotherapy and Biomarkers
(32)
Affiliations
Lahey Hospital and Medical Center
Barnes-Jewish Hospital
Cleveland Clinic
University of Queensland
Pfizer (United States)